These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 35670527)
1. Chemical and Chemo-Enzymatic Syntheses of Glycans Containing Ribitol Phosphate Scaffolding of Matriglycan. Tamura JI; Tamura T; Hoshino S; Imae R; Kato R; Yokono M; Nagase M; Ohno S; Manabe N; Yamaguchi Y; Manya H; Endo T ACS Chem Biol; 2022 Jun; 17(6):1513-1523. PubMed ID: 35670527 [TBL] [Abstract][Full Text] [Related]
2. The Muscular Dystrophy Gene TMEM5 Encodes a Ribitol β1,4-Xylosyltransferase Required for the Functional Glycosylation of Dystroglycan. Manya H; Yamaguchi Y; Kanagawa M; Kobayashi K; Tajiri M; Akasaka-Manya K; Kawakami H; Mizuno M; Wada Y; Toda T; Endo T J Biol Chem; 2016 Nov; 291(47):24618-24627. PubMed ID: 27733679 [TBL] [Abstract][Full Text] [Related]
3. Endogenous reductase activities for the generation of ribitol-phosphate, a CDP-ribitol precursor, in mammals. Hoshino S; Manya H; Imae R; Kobayashi K; Kanagawa M; Endo T J Biochem; 2024 Mar; 175(4):418-425. PubMed ID: 38140954 [TBL] [Abstract][Full Text] [Related]
4. Crystal structures of fukutin-related protein (FKRP), a ribitol-phosphate transferase related to muscular dystrophy. Kuwabara N; Imae R; Manya H; Tanaka T; Mizuno M; Tsumoto H; Kanagawa M; Kobayashi K; Toda T; Senda T; Endo T; Kato R Nat Commun; 2020 Jan; 11(1):303. PubMed ID: 31949166 [TBL] [Abstract][Full Text] [Related]
5. CDP-glycerol inhibits the synthesis of the functional Imae R; Manya H; Tsumoto H; Osumi K; Tanaka T; Mizuno M; Kanagawa M; Kobayashi K; Toda T; Endo T J Biol Chem; 2018 Aug; 293(31):12186-12198. PubMed ID: 29884773 [TBL] [Abstract][Full Text] [Related]
6. Cell endogenous activities of fukutin and FKRP coexist with the ribitol xylosyltransferase, TMEM5. Nishihara R; Kobayashi K; Imae R; Tsumoto H; Manya H; Mizuno M; Kanagawa M; Endo T; Toda T Biochem Biophys Res Commun; 2018 Mar; 497(4):1025-1030. PubMed ID: 29477842 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory machinery for the functional dystroglycan glycosylation. Kondo Y; Okajima T J Biochem; 2023 Apr; 173(5):333-335. PubMed ID: 36760122 [TBL] [Abstract][Full Text] [Related]
8. Glycosylation with ribitol-phosphate in mammals: New insights into the O-mannosyl glycan. Manya H; Endo T Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2462-2472. PubMed ID: 28711406 [TBL] [Abstract][Full Text] [Related]
9. The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition. Praissman JL; Willer T; Sheikh MO; Toi A; Chitayat D; Lin YY; Lee H; Stalnaker SH; Wang S; Prabhakar PK; Nelson SF; Stemple DL; Moore SA; Moremen KW; Campbell KP; Wells L Elife; 2016 Apr; 5():. PubMed ID: 27130732 [TBL] [Abstract][Full Text] [Related]
10. NAD+ enhances ribitol and ribose rescue of α-dystroglycan functional glycosylation in human FKRP-mutant myotubes. Ortiz-Cordero C; Magli A; Dhoke NR; Kuebler T; Selvaraj S; Oliveira NA; Zhou H; Sham YY; Bang AG; Perlingeiro RC Elife; 2021 Jan; 10():. PubMed ID: 33513091 [TBL] [Abstract][Full Text] [Related]
11. PCYT2 synthesizes CDP-glycerol in mammals and reduced PCYT2 enhances the expression of functionally glycosylated α-dystroglycan. Imae R; Manya H; Tsumoto H; Miura Y; Endo T J Biochem; 2021 Oct; 170(2):183-194. PubMed ID: 34255834 [TBL] [Abstract][Full Text] [Related]
12. Ribitol enhances matriglycan of α-dystroglycan in breast cancer cells without affecting cell growth. Lu PJ; Tucker JD; Branch EK; Guo F; Blaeser AR; Lu QL Sci Rep; 2020 Mar; 10(1):4935. PubMed ID: 32188898 [TBL] [Abstract][Full Text] [Related]
13. Establishment of a novel monoclonal antibody against truncated glycoforms of α-dystroglycan lacking matriglycans. Yamasaki F; Umezawa F; Sensui T; Anzo M; Abo H; Kuo CW; Khoo KH; Kato K; Yagi H; Kawashima H Biochem Biophys Res Commun; 2021 Nov; 579():8-14. PubMed ID: 34583196 [TBL] [Abstract][Full Text] [Related]
14. ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto α-dystroglycan. Gerin I; Ury B; Breloy I; Bouchet-Seraphin C; Bolsée J; Halbout M; Graff J; Vertommen D; Muccioli GG; Seta N; Cuisset JM; Dabaj I; Quijano-Roy S; Grahn A; Van Schaftingen E; Bommer GT Nat Commun; 2016 May; 7():11534. PubMed ID: 27194101 [TBL] [Abstract][Full Text] [Related]
15. Identification of a Post-translational Modification with Ribitol-Phosphate and Its Defect in Muscular Dystrophy. Kanagawa M; Kobayashi K; Tajiri M; Manya H; Kuga A; Yamaguchi Y; Akasaka-Manya K; Furukawa JI; Mizuno M; Kawakami H; Shinohara Y; Wada Y; Endo T; Toda T Cell Rep; 2016 Mar; 14(9):2209-2223. PubMed ID: 26923585 [TBL] [Abstract][Full Text] [Related]
16. Stereo- and Regioselective Synthesis of Tamura T; Omura Y; Tamura JI J Org Chem; 2020 Oct; 85(20):12935-12946. PubMed ID: 32930586 [TBL] [Abstract][Full Text] [Related]
17. Improved efficacy of FKRP AAV gene therapy by combination with ribitol treatment for LGMD2I. Cataldi MP; Vannoy CH; Blaeser A; Tucker JD; Leroy V; Rawls R; Killilee J; Holbrook MC; Lu QL Mol Ther; 2023 Dec; 31(12):3478-3489. PubMed ID: 37919902 [TBL] [Abstract][Full Text] [Related]
18. Expression in retinal neurons of fukutin and FKRP, the protein products of two dystroglycanopathy-causative genes. Haro C; Uribe ML; Quereda C; Cruces J; Martín-Nieto J Mol Vis; 2018; 24():43-58. PubMed ID: 29416295 [TBL] [Abstract][Full Text] [Related]
19. The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated α-dystroglycan functional glycosylation. Willer T; Inamori K; Venzke D; Harvey C; Morgensen G; Hara Y; Beltrán Valero de Bernabé D; Yu L; Wright KM; Campbell KP Elife; 2014 Oct; 3():. PubMed ID: 25279699 [TBL] [Abstract][Full Text] [Related]